PuSH - Publication Server of Helmholtz Zentrum München: Lrh1/nr5a2 conveys the anti-diabetic effects of the agonist bl001 and promotes alpha-to-beta-cell conversion in streptozotocin-treated mice.

Navigation

Home

Deutsch

Research

Advanced Search

Browse by ...

... Journal

... Publication Type

... Research Data

... Publication Year

Publication overview

Support & Contact

Contact persons

Help

Data protection

Cobo-Vuilleumier, N.* ; Martin-Vazquez, E.* ; Lorenzo, P.I.* ; Diaz-Contreras, I.* ; Martin, F.* ; Gerdes, J.M. ; Ferrer, J.* ; Romero-Zerbo, Y.S.* ; Garcia, M.* ; Bermudez-Silva, F.J.* ; Gannon, M.* ; Collombat, P.* ; Gauthier, B.R.*

Lrh1/nr5a2 conveys the anti-diabetic effects of the agonist bl001 and promotes alpha-to-beta-cell conversion in streptozotocin-treated mice.

Diabetologia 63, 1, S182-S183 (2020)

Open Access Green as soon as Postprint is submitted to ZB.

Abstract
Metrics
Extra information

Additional Metrics?

[➜Log in]

Edit extra informations Login

Publication type Article: Journal article

Document type Meeting abstract

Corresponding Author

ISSN (print) / ISBN 0012-186X

e-ISSN 1432-0428

Journal Diabetologia

Quellenangaben Volume: 63, Pages: S182-S183, Supplement: 1

Publisher Springer

Publishing Place Berlin ; Heidelberg [u.a.]

Non-patent literature Publications

Reviewing status Peer reviewed

Institute(s) Institute of Diabetes and Regeneration Research (IDR)